Rom Rodney Karin, MD
Otolaryngology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Karin’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G53047 · Current
Licensed to practise in California · since 1984 · expires 2027-09-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA2.07% owner since 1999 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA2.07% owner since 1999 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$97,898
Medicare paid this office $97,898 for 287 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 93 | $14,276 | $114 |
| Diagnostic exam of nasal passages using an endoscope | 57 | $13,127 | $182 |
| New patient visit (45+ min) | 68 | $9,101 | $134 |
| Diagnostic exam of voice box using a flexible endoscope | 51 | $6,688 | $119 |
| Long return visit (40+ min) | 31 | $5,993 | $171 |
See all 10 services
| Return visit (30+ min) | 93 | $14,276 | $114 |
| Diagnostic exam of nasal passages using an endoscope | 57 | $13,127 | $182 |
| New patient visit (45+ min) | 68 | $9,101 | $134 |
| Diagnostic exam of voice box using a flexible endoscope | 51 | $6,688 | $119 |
| Long return visit (40+ min) | 31 | $5,993 | $171 |
| New patient visit (30+ min) | 66 | $5,782 | $88 |
| Short return visit (20+ min) | 60 | $4,968 | $69 |
| Removal of impacted ear wax | 88 | $3,379 | $34 |
| New patient visit (60+ min) | 15 | $3,118 | $208 |
| Exam of ear using a microscope | 42 | $1,146 | $25 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
287 Original Medicare patients in 2024. Average age 77 · Women 57% · Also on Medicaid 10% · Health risk score 1.09. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 69% · Coronary heart disease 28% · Diabetes 22% · Chronic kidney disease 19% · Cancer 18% · Atrial fibrillation 17% · Depression 14% · Heart failure 12% · COPD 8% · Stroke 6% · Dementia 5%.
The office billed $524,531, Medicare allowed $133,568 and paid $97,898; for 775 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 287 | 775 | 77 | 1.09 | $524,531 | $97,898 |
| 2023 | 300 | 883 | 76 | 1.14 | $713,657 | $116,057 |
| 2022 | 306 | 883 | 76 | 1.08 | $552,442 | $117,350 |
| 2021 | 222 | 726 | 77 | 1.15 | $473,126 | $104,417 |
| 2020 | 193 | 574 | 77 | 1.21 | $358,410 | $73,497 |
| 2019 | 220 | 599 | 76 | 1.27 | $343,639 | $75,861 |
| 2018 | 217 | 625 | 76 | 1.15 | $242,124 | $70,739 |
| 2017 | 269 | 870 | 76 | 1.20 | $133,542 | $91,037 |
| 2016 | 260 | 798 | 76 | 1.18 | $134,032 | $89,519 |
| 2015 | 276 | 867 | 76 | 1.16 | $146,697 | $98,306 |
| 2014 | 260 | 730 | 75 | 1.12 | $147,023 | $91,308 |
| 2013 | 247 | 697 | 75 | 1.04 | $127,573 | $86,637 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Diagnostic exam of nasal passages using an endoscope | 66 | $18,055 | $186 |
| Return visit (30+ min) | 105 | $17,331 | $115 |
| Diagnostic exam of voice box using a flexible endoscope | 73 | $10,419 | $127 |
| New patient visit (45+ min) | 71 | $10,308 | $145 |
| Long return visit (40+ min) | 39 | $7,816 | $156 |
| New patient visit (30+ min) | 69 | $6,967 | $101 |
| Short return visit (20+ min) | 60 | $6,710 | $80 |
| Removal of impacted ear wax | 93 | $4,343 | $39 |
| New patient visit (60+ min) | 20 | $4,191 | $210 |
| Complex control of nose bleed | 14 | $4,143 | $259 |
| Exam of ear using a microscope | 12 | $339 | $28 |
2022: 10 services
| Diagnostic exam of nasal passages using an endoscope | 60 | $14,062 | $183 |
| Return visit (30+ min) | 80 | $13,460 | $120 |
| Diagnostic exam of voice box using a flexible endoscope | 77 | $12,963 | $134 |
| Long return visit (40+ min) | 65 | $12,735 | $159 |
| New patient visit (45+ min) | 71 | $10,662 | $150 |
| New patient visit (60+ min) | 46 | $9,162 | $199 |
| Short return visit (20+ min) | 67 | $6,714 | $84 |
| New patient visit (30+ min) | 63 | $5,709 | $91 |
| Removal of impacted ear wax | 88 | $4,561 | $40 |
| Ct scan of face without contrast | 22 | $2,968 | $129 |
2021: 11 services
| Long return visit (40+ min) | 71 | $16,785 | $175 |
| Return visit (30+ min) | 65 | $10,222 | $116 |
| Diagnostic exam of voice box using a flexible endoscope | 49 | $8,569 | $126 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $8,549 | $194 |
| New patient visit (45+ min) | 51 | $8,290 | $163 |
| New patient visit (60+ min) | 33 | $7,148 | $217 |
| Short return visit (20+ min) | 51 | $5,238 | $82 |
| Ct scan of face without contrast | 27 | $4,190 | $150 |
| Removal of impacted ear wax | 76 | $3,348 | $36 |
| New patient visit (30+ min) | 32 | $2,950 | $92 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $407 | $31 |
2020: 8 services
| Return visit (30+ min) | 101 | $16,567 | $106 |
| New patient visit (45+ min) | 52 | $7,813 | $150 |
| Diagnostic exam of voice box using a flexible endoscope | 41 | $6,535 | $121 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $5,247 | $187 |
| Short return visit (20+ min) | 43 | $4,060 | $67 |
| New patient visit (30+ min) | 37 | $3,850 | $104 |
| Ct scan of face without contrast | 19 | $3,223 | $140 |
| Removal of impacted ear wax | 48 | $2,281 | $38 |
2019: 8 services
| Return visit (30+ min) | 108 | $17,200 | $101 |
| New patient visit (45+ min) | 70 | $10,653 | $152 |
| Diagnostic exam of nasal passages using an endoscope | 24 | $7,784 | $205 |
| Diagnostic exam of voice box using a flexible endoscope | 47 | $7,614 | $115 |
| New patient visit (30+ min) | 37 | $3,676 | $99 |
| Short return visit (20+ min) | 39 | $3,410 | $70 |
| Removal of impacted ear wax | 50 | $2,488 | $41 |
| Ct scan of face without contrast | 11 | $1,878 | $144 |
2018: 11 services
| Return visit (30+ min) | 117 | $17,132 | $93 |
| New patient visit (45+ min) | 73 | $10,521 | $144 |
| Diagnostic exam of nasal passages using an endoscope | 32 | $10,290 | $206 |
| Diagnostic exam of voice box using a flexible endoscope | 41 | $6,013 | $107 |
| Ct scan of face without contrast | 19 | $3,485 | $139 |
| New patient visit (30+ min) | 25 | $1,915 | $77 |
| Short return visit (20+ min) | 17 | $1,538 | $59 |
| Removal of impacted ear wax | 34 | $1,470 | $40 |
| Comprehensive hearing and speech recognition test | 19 | $448 | $24 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 14 | $329 | $23 |
| Test to assess middle ear function | 19 | $184 | $10 |
2017: 12 services
| Return visit (30+ min) | 137 | $20,375 | $90 |
| Diagnostic exam of nasal passages using an endoscope | 30 | $11,192 | $211 |
| Diagnostic exam of voice box using a flexible endoscope | 60 | $9,731 | $109 |
| New patient visit (45+ min) | 66 | $7,986 | $121 |
| New patient visit (30+ min) | 47 | $4,302 | $92 |
| Ct scan of face without contrast | 22 | $3,536 | $141 |
| Comprehensive hearing and speech recognition test | 60 | $2,323 | $33 |
| Long return visit (40+ min) | 16 | $2,166 | $127 |
| Short return visit (20+ min) | 30 | $2,096 | $58 |
| New patient visit (60+ min) | 12 | $2,093 | $174 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 53 | $1,911 | $30 |
| Test to assess middle ear function | 59 | $920 | $13 |
2016: 10 services
| Return visit (30+ min) | 126 | $17,722 | $91 |
| New patient visit (45+ min) | 100 | $14,027 | $140 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $8,587 | $209 |
| Diagnostic exam of voice box using a flexible endoscope | 52 | $7,877 | $109 |
| Ct scan of face without contrast | 41 | $6,295 | $140 |
| Short return visit (20+ min) | 41 | $3,799 | $64 |
| New patient visit (30+ min) | 33 | $2,776 | $84 |
| Comprehensive hearing and speech recognition test | 49 | $1,661 | $31 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 40 | $1,226 | $29 |
| Test to assess middle ear function | 48 | $674 | $13 |
2015: 12 services
| Return visit (30+ min) | 132 | $18,798 | $90 |
| New patient visit (45+ min) | 101 | $13,927 | $138 |
| Diagnostic exam of nasal passages using an endoscope | 29 | $11,063 | $209 |
| Diagnostic exam of voice box using a flexible endoscope | 57 | $7,984 | $105 |
| Ct scan of face without contrast | 34 | $6,369 | $136 |
| New patient visit (60+ min) | 16 | $2,977 | $186 |
| Long return visit (40+ min) | 22 | $2,915 | $121 |
| Short return visit (20+ min) | 35 | $2,773 | $60 |
| Comprehensive hearing and speech recognition test | 59 | $2,044 | $30 |
| New patient visit (30+ min) | 19 | $1,726 | $91 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 37 | $1,137 | $29 |
| Test to assess middle ear function | 56 | $779 | $12 |
2014: 12 services
| New patient visit (45+ min) | 107 | $14,926 | $139 |
| Return visit (30+ min) | 102 | $13,943 | $92 |
| Diagnostic exam of nasal passages using an endoscope | 29 | $10,723 | $210 |
| Ct scan of face without contrast | 43 | $9,017 | $184 |
| Diagnostic exam of voice box using a flexible endoscope | 45 | $5,874 | $111 |
| Long return visit (40+ min) | 36 | $4,314 | $105 |
| Short return visit (20+ min) | 36 | $2,997 | $64 |
| New patient visit (60+ min) | 12 | $2,258 | $188 |
| New patient visit (30+ min) | 21 | $1,892 | $90 |
| Comprehensive hearing and speech recognition test | 36 | $1,324 | $35 |
| Removal of impacted ear wax | 17 | $847 | $42 |
| Test to assess middle ear function | 34 | $495 | $14 |
2013: 13 services
| Return visit (30+ min) | 92 | $13,970 | $95 |
| New patient visit (45+ min) | 80 | $11,437 | $143 |
| Diagnostic exam of nasal passages using an endoscope | 27 | $10,106 | $215 |
| Ct scan of face without contrast | 35 | $8,716 | $229 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $6,672 | $111 |
| Complex control of nose bleed | 13 | $2,749 | $211 |
| Long return visit (40+ min) | 21 | $2,658 | $121 |
| New patient visit (60+ min) | 14 | $2,370 | $169 |
| New patient visit (30+ min) | 26 | $2,335 | $90 |
| Short return visit (20+ min) | 25 | $1,845 | $60 |
| Comprehensive hearing and speech recognition test | 41 | $1,500 | $31 |
| Removal of impacted ear wax | 29 | $1,279 | $40 |
| Test to assess middle ear function | 39 | $546 | $12 |
Drugs they prescribed that Part D paid
$11,470
Pharmacies billed $11,470 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (15 of 354) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
350 generic and fewer than 11 brand-name prescriptions · $11,470 in drug cost · 61 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 47 | $1,614 | $34 |
| Cevimeline | 11 | $1,487 | $135 |
| Fluticasone Propionate | 59 | $1,032 | $17 |
| Budesonide | 11 | $636 | $58 |
| Omeprazole | 33 | $564 | $17 |
See all 11 drugs
| Ipratropium | 47 | $1,614 | $34 |
| Cevimeline | 11 | $1,487 | $135 |
| Fluticasone Propionate | 59 | $1,032 | $17 |
| Budesonide | 11 | $636 | $58 |
| Omeprazole | 33 | $564 | $17 |
| Celecoxib | 11 | $469 | $43 |
| Amoxicillin-Clavulanate Potass | 25 | $313 | $13 |
| Pantoprazole | 11 | $206 | $19 |
| Prednisone | 31 | $187 | $6 |
| Mupirocin | 12 | $100 | $8 |
| Oxycodone | 12 | $49 | $4 |
Year by year
| 2024 | 354 | 134 | 4% (15) | None | $11,470 |
| 2023 | 415 | 141 | 3% (12) | None | $14,845 |
| 2022 | 403 | 141 | 4% (14) | 3% | $16,454 |
| 2021 | 395 | 129 | 4% (15) | 5% | $21,384 |
| 2020 | 365 | 103 | 4% (13) | 10% | $24,225 |
| 2019 | 374 | 111 | 4% (13) | 17% | $23,779 |
| 2018 | 356 | 101 | None | 17% | $19,147 |
| 2017 | 371 | 108 | 4% (14) | 14% | $16,958 |
| 2016 | 413 | 107 | None | 12% | $17,580 |
| 2015 | 455 | 116 | 3% (14) | 17% | $26,515 |
| 2014 | 446 | 120 | 3% (14) | 20% | $24,665 |
| 2013 | 336 | 97 | None | 14% | $18,852 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Ipratropium | 78 | $2,896 | $37 |
| Budesonide | 13 | $1,350 | $104 |
| Fluticasone Propionate | 53 | $1,336 | $25 |
| Omeprazole | 54 | $640 | $12 |
| Amoxicillin-Clavulanate Potass | 28 | $627 | $22 |
| Azelastine | 11 | $361 | $33 |
| Mupirocin | 28 | $307 | $11 |
| Prednisone | 22 | $72 | $3 |
2022: 10 drugs
| Ipratropium | 84 | $4,092 | $49 |
| Fluticasone Propionate | 66 | $1,836 | $28 |
| Omeprazole | 66 | $1,251 | $19 |
| Azelastine | 12 | $763 | $64 |
| Cefuroxime | 12 | $379 | $32 |
| Amoxicillin-Clavulanate Potass | 24 | $359 | $15 |
| Pantoprazole | 11 | $114 | $10 |
| Hydrocodone-Acetaminophen | 11 | $99 | $9 |
| Mupirocin | 20 | $93 | $5 |
| Prednisone | 15 | $57 | $4 |
2021: 9 drugs
| Ipratropium | 112 | $6,366 | $57 |
| Omeprazole | 66 | $1,023 | $16 |
| Fluticasone Propionate | 41 | $958 | $23 |
| Cefuroxime | 20 | $572 | $29 |
| Azelastine | 11 | $349 | $32 |
| Amoxicillin-Clavulanate Potass | 13 | $297 | $23 |
| Mupirocin | 21 | $248 | $12 |
| Hydrocodone-Acetaminophen | 14 | $123 | $9 |
| Prednisone | 15 | $113 | $8 |
2020: 7 drugs
| Ipratropium | 79 | $3,947 | $50 |
| Fluticasone Propionate | 64 | $1,818 | $28 |
| Omeprazole | 62 | $1,194 | $19 |
| Synthroid | 12 | $568 | $47 |
| Clarithromycin | 12 | $565 | $47 |
| Amoxicillin-Clavulanate Potass | 16 | $228 | $14 |
| Hydrocodone-Acetaminophen | 13 | $74 | $6 |
2019: 9 drugs
| Qnasl | 12 | $2,882 | $240 |
| Ipratropium | 56 | $2,174 | $39 |
| Fluticasone Propionate | 38 | $1,013 | $27 |
| Omeprazole | 44 | $989 | $22 |
| Clarithromycin | 16 | $756 | $47 |
| Synthroid | 13 | $492 | $38 |
| Azelastine | 13 | $490 | $38 |
| Amoxicillin-Clavulanate Potass | 22 | $418 | $19 |
| Hydrocodone-Acetaminophen | 11 | $125 | $11 |
2018: 12 drugs
| Dymista | 18 | $3,505 | $195 |
| Qnasl | 12 | $2,620 | $218 |
| Ipratropium | 60 | $2,339 | $39 |
| Omeprazole | 53 | $999 | $19 |
| Fluticasone Propionate | 43 | $732 | $17 |
| Cefuroxime | 15 | $562 | $37 |
| Synthroid | 11 | $398 | $36 |
| Pantoprazole | 16 | $397 | $25 |
| Amoxicillin-Clavulanate Potass | 12 | $270 | $23 |
| Levothyroxine | 12 | $245 | $20 |
| Prednisone | 13 | $134 | $10 |
| Mupirocin | 14 | $124 | $9 |
2017: 14 drugs
| Qnasl | 12 | $2,315 | $193 |
| Cevimeline | 11 | $2,259 | $205 |
| Ipratropium | 47 | $1,670 | $36 |
| Azelastine | 21 | $1,318 | $63 |
| Fluticasone Propionate | 51 | $771 | $15 |
| Omeprazole | 42 | $584 | $14 |
| Synthroid | 13 | $455 | $35 |
| Cefuroxime | 12 | $413 | $34 |
| Pantoprazole | 13 | $280 | $22 |
| Levothyroxine | 18 | $279 | $16 |
| Amoxicillin-Clavulanate Potass | 14 | $212 | $15 |
| Mupirocin | 18 | $133 | $7 |
| Prednisone | 11 | $70 | $6 |
| Hydrocodone-Acetaminophen | 12 | $67 | $6 |
2016: 11 drugs
| Dymista | 14 | $2,482 | $177 |
| Qnasl | 11 | $2,008 | $183 |
| Ipratropium | 65 | $1,641 | $25 |
| Azelastine | 14 | $1,111 | $79 |
| Fluticasone Propionate | 83 | $989 | $12 |
| Omeprazole | 60 | $840 | $14 |
| Dapsone | 11 | $780 | $71 |
| Pantoprazole | 13 | $385 | $30 |
| Levothyroxine | 20 | $363 | $18 |
| Amoxicillin-Clavulanate Potass | 18 | $339 | $19 |
| Mupirocin | 12 | $144 | $12 |
2015: 11 drugs
| Qnasl | 18 | $2,702 | $150 |
| Fluticasone Propionate | 92 | $1,297 | $14 |
| Ipratropium | 32 | $1,054 | $33 |
| Cefuroxime | 14 | $1,011 | $72 |
| Omeprazole | 49 | $751 | $15 |
| Amoxicillin-Clavulanate Potass | 30 | $537 | $18 |
| Pantoprazole | 13 | $427 | $33 |
| Levothyroxine | 17 | $413 | $24 |
| Hydrocodone-Acetaminophen | 13 | $397 | $31 |
| Dapsone | 11 | $330 | $30 |
| Prednisone | 19 | $143 | $8 |
2014: 12 drugs
| Nasonex | 11 | $2,017 | $183 |
| Fluticasone Propionate | 126 | $1,901 | $15 |
| Qnasl | 11 | $1,411 | $128 |
| Cefuroxime | 19 | $1,036 | $55 |
| Ipratropium | 30 | $834 | $28 |
| Omeprazole | 33 | $569 | $17 |
| Levocetirizine Dihydrochloride | 12 | $524 | $44 |
| Triamcinolone Acetonide | 16 | $472 | $30 |
| Flunisolide | 11 | $448 | $41 |
| Hydrocodone-Acetaminophen | 12 | $396 | $33 |
| Amox Tr-Potassium Clavulanate | 14 | $262 | $19 |
| Levothyroxine | 14 | $177 | $13 |
2013: 7 drugs
| Fluticasone Propionate | 95 | $2,276 | $24 |
| Omeprazole | 25 | $400 | $16 |
| Ipratropium | 18 | $322 | $18 |
| Cefuroxime | 14 | $310 | $22 |
| Mupirocin | 18 | $214 | $12 |
| Levothyroxine | 13 | $163 | $13 |
| Prednisone | 17 | $115 | $7 |
Money from drug and device companies
$451 in 2025
| 2025 | 6 | 10 | None | $451 |
| 2024 | 2 | 2 | None | $49 |
| 2023 | 3 | 4 | None | $116 |
| 2022 | 1 | 1 | None | $59 |
| 2021 | 1 | 2 | None | $54 |
| 2020 | 4 | 6 | None | $225 |
| 2019 | 4 | 7 | None | $154 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Tula | $130 | 5 payments
|
| Genzyme | Dupixent | $124 | 1 payment
|
| GlaxoSmithKline | None | $118 | 1 payment
|
| Integra LifeSciences | Acclarent Aera | $32 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
| Ethicon US | Stratafix | $23 | 1 payment
|
See all 10 published payments
| Integra LifeSciences | Meals · 2025-12-05 | Acclarent Aera | $32 |
| Ethicon US | Meals · 2025-09-26 | Stratafix | $23 |
| Genzyme | Meals · 2025-07-12 | Dupixent | $124 |
| GlaxoSmithKline | Meals · 2025-07-11 | None | $118 |
| Smith+Nephew | Meals · 2025-04-08 | Tula | $33 |
| Smith+Nephew | Meals · 2025-03-11 | Tula | $22 |
| Smith+Nephew | Meals · 2025-03-04 | Tula | $23 |
| Smith+Nephew | Meals · 2025-01-16 | Halo | $27 |
| Smith+Nephew | Meals · 2025-01-16 | Halo | $24 |
| Exact Sciences | Meals · 2025-01-15 | Cologuard Collection Kit | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $49
| GlaxoSmithKline | Nucala | $25 | 1 payment
|
| Smith+Nephew | Halo | $24 | 1 payment
|
2023: $116
| Medtronic | Stealthstation S8 Platform | $63 | 1 payment
|
| Smith+Nephew | Halo | $32 | 2 payments
|
| Merck Sharp & Dohme | Bridion | $20 | 1 payment
|
2022: $59
| Intersect ENT | Sinuva | $59 | 1 payment
|
2021: $54
| Optinose US | Xhance | $54 | 2 payments
|
2020: $225
| Genzyme | Dupixent | $125 | 1 payment
|
| OptiNose US | Xhance | $64 | 3 payments
|
| Intersect ENT | Sinuva | $22 | 1 payment
|
| Ethicon US | Vistaseal | $14 | 1 payment
|
2019: $154
| Smith+Nephew | Coblation - Turbinate Wands | $52 | 3 payments
|
| OptiNose US | Xhance | $42 | 2 payments
|
| Stryker | Entellus - Xpress Ent Dilation System | $35 | 1 payment
|
| Intersect ENT | Propel | $25 | 1 payment
|
Professional record
- NPI
- 1871595223
- Licence
- CA G53047California G53047: Current · expires 2027-09-30
- Trained
- University of California, Geffen School of Medicine, 1983
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G530470
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 15861 Winchester Blvd, Los Gatos, CA, 95030
- NPI first listed
- 2005-08-15
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305